A comparative study of once-daily vs twice-daily tacrolimus in deceased donor kidney transplant recipients: a national cohort analysis

This publication has 27 references indexed in Scilit:

• Incomplete reporting of clinically significant acute rejection episodes in the national kidney transplant registry
  American Journal of Transplantation, 2024
• Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients
  Scientific Reports, 2021
• CYP3A5 gene polymorphisms and their impact on dosage and trough concentration of tacrolimus among kidney transplant patients: a systematic review and meta-analysis
  The Pharmacogenomics Journal, 2020
• Association of Kidney Transplant Center Volume With 3-Year Clinical Outcomes
  American Journal of Kidney Diseases, 2019
• Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients
  American Journal of Kidney Diseases, 2018
• Worldwide Distribution of Cytochrome P450 Alleles: A Meta‐analysis of Population‐scale Sequencing Projects
  Clinical Pharmacology & Therapeutics, 2017
• Meltdose Tacrolimus Pharmacokinetics
  Transplantation Proceedings, 2016
• Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing
  Clinical Pharmacology & Therapeutics, 2015
• MDR1 Haplotypes Conferring an Increased Expression of Intestinal CYP3A4 Rather than MDR1 in Female Living-Donor Liver Transplant Patients
  Pharmaceutical Research, 2009
• Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
  New England Journal of Medicine, 2007